Desmoplastic Small Round Cell Tumor Treatment Market Forecast 2020-2026 | Size, Share, Growth, Trends, Segmentation, Analysis and In-Depth Research Report 2020

SEATTLE, March 25, 2021, (PHARMIWEB) — Global Desmoplastic Small Round Cell Tumor (DSRCT) Treatment Market

Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver. According to the National Institute of Health, the disease primarily affects children and young adults, as is more prevalent in males than that in females. According to the Health Program of European Union, DSRCT is an extremely rare condition and only a few hundred cases have been reported worldwide till 2011 since its first description in 1989. Moreover, according to the National Cancer Intelligent Network, Public Health England, only three cases of DSRCT were reported between 2010 and 2013 in England.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1569

The Desmoplastic Small Round Cell tumor is formed by small, round cancer cells that are surrounded by scar-like tissue that are found in the peritoneum lining inside of the abdomen and pelvis. The tumor cells also undergo a characteristic genetic change that involves translocation among chromosomes 11 and 22 that differentiates the tumor from various other cancerous tumors. This genetic change is not inherited and has no linear parental linkage. The common symptoms of DSRCT includes increase in abdominal mass, feeling of fullness as well as gastrointestinal obstruction such as constipation. The DSRCT spreads locally to the lymph nodes and on the linings of the abdomen. This tumor is also found to spread into the lungs, bones, and liver aggressively, being metastatic in nature. According to a review article published by the Cancer Research Center Lyon in 2012, the mean age for diagnosis of DSRCT is approximately 22 years to 25 years, wherein the male to female ratio is 4:1.

Global Desmoplastic Small Round Cell Tumor Treatment Market Dynamics

Increasing incidence of genetic disorders and cancer are among the major factors responsible for the growth of the global desmoplastic small round cell tumor treatment market. According to a report published by the Genetics Education Center, University of Kansas Medical Center, in 2012, around 12% of the hospital admissions recorded in the U.S. accounted for the treatment of genetic causes in 2013. Moreover, the American Cancer Society reported that the cancer affecting the stomach, small intestine, and gastrointestinal cavity, is one of the most common cancers of the digestive system. In 2016, the Cancer Research UK reported that rare cancers affects up to 2 of every 100,000 people. Additionally, increasing research & development to improve conditions of the patients suffering with rare cancers is also responsible to augment the market growth. For instance, the Memorial Sloan Kettering Cancer Center is conducting Phase 1 clinical trials to develop an intraperitoneal radiotherapy for patients suffering with desmoplastic small round cell tumors and is expected to complete its Phase 1 trial by April 2018.

Exclusive offer!!! Purchase the report at a discounted rate!!!

Apply Promo Code “CMIFIRST1000” and Get Up to 30% Discount

Quick Buy – Desmoplastic Small Round Cell Tumor Treatment Market Research Report: https://bit.ly/3rm29H9

Global Desmoplastic Small Round Cell Tumor Treatment Market – Regional Insights

North America holds a dominant position in the global desmoplastic small round cell tumor treatment market, owing to government and non-government initiatives undertaken to increase awareness regarding the rare cancers. For instance, the National Organization for Rare Disorders and Rare Cancer Alliance is focusing on offering information and provide support to adult and pediatric patients by providing them with cancer information, treatment options, and rare cancer differences. In addition, extensive research and development to determine the underlying cause and early detection of these diseases is being conducted in North America, which makes the region a leader in the global market. For instance, the Mayo Foundation of Medical Education & Research is focusing on very specific research to determine the factors that are responsible to delay the diagnosis of soft tissue sarcomas in patients.

On the contrary, Asia Pacific is expected to gain significant traction in the global market, owing to the improving healthcare infrastructure and increasing research funding by government, as well as non-government organizations. For instance, the Australian Government Department of Health invested US$ 13 Million to stimulate clinical trial registry for under-researched health priorities, such as rare cancers and rare diseases.

Competitive Analysis

The key players operating in the global desmoplastic small round cell tumor treatment market include Glentham Lifesciences Ltd., Novartis AG, NantCell, Inc., Daiichi Sankyo, Inc., and F. Hoffmann-L-Roche.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/desmoplastic-small-round-cell-tumor-treatment-market-1569

Market Taxonomy

On the basis of treatment type:

• Chemotherapy Drugs
  • Doxorubicin
  • Vincristine
  • Etoposide
  • Carboplatin
  • Cyclophaophamide
• Surgical Tumor Removal
• Radiotherapy

By end-user:

• Hospitals
• Cancer Treatment Centers
• Others

Table of Content

Global Desmoplastic Small Round Cell Tumor Treatment Market Research Report
Section 1: Global Desmoplastic Small Round Cell Tumor Treatment Industry Overview
Section 2: Global Economic Impact on Desmoplastic Small Round Cell Tumor Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Desmoplastic Small Round Cell Tumor Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Desmoplastic Small Round Cell Tumor Treatment Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837